Cargando...
Efficacy and Economic Value of Adjuvant Imatinib for Gastrointestinal Stromal Tumors
OBJECTIVE. This article presents the clinical effectiveness and cost-effectiveness of the use of adjuvant imatinib mesylate for treating patients with localized primary gastrointestinal stromal tumors (GISTs) and discusses the impact of prolonged treatment with adjuvant imatinib on health care costs...
Gardado en:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
AlphaMed Press
2013
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4063396/ https://ncbi.nlm.nih.gov/pubmed/23709752 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0474 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|